Literature DB >> 2093471

gamma-Glutamylglutamine identified in plasma and cerebrospinal fluid from hyperammonaemic patients.

J W Hammond1, M Potter, R Truscott, B Wilcken.   

Abstract

gamma-Glutamylglutamine has been identified in plasma and cerebrospinal fluid. Preparative high voltage electrophoresis was used to isolate the compound from two to three ml of sample. Analysis of archival material from eight patients with urea cycle disorders showed that plasma gamma-glutamylglutamine was 20-214 mumol/l when the plasma glutamine was greater than 1,000 mumol/l and that the relationship was strongly positive (P less than 0.0005). Plasma gamma-glutamylglutamine concentration was also raised in one patient with secondary hyperammonaemia, but not in three other cases, one of whom had a plasma glutamine of 10,000 mumol/l. Cerebrospinal fluid from the last patient contained 97 mumol/l of gamma-glutamylglutamine. Samples of cerebrospinal fluid from two patients with urea cycle disorders were available and the gamma-glutamylglutamine levels were 203 and 313 mumol/l. gamma-Glutamylglutamine and 5-oxoproline concentrations were not significantly increased in urine from any of these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2093471     DOI: 10.1016/0009-8981(90)90132-c

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Reduced glutathione, gamma-glutamylcysteine, cysteine and gamma-glutamylglutamine in gamma-glutamyltransferase deficiency.

Authors:  J W Hammond; M Potter; K G Sim; B Wilcken
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Cerebrospinal fluid as a tool in the diagnosis of neurometabolic diseases: amino acid analysis before and after acid hydrolysis.

Authors:  J Jaeken
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

3.  Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia.

Authors:  Austin L Brown; Pagna Sok; Olga Taylor; John P Woodhouse; M Brooke Bernhardt; Kimberly P Raghubar; Lisa S Kahalley; Philip J Lupo; Marilyn J Hockenberry; Michael E Scheurer
Journal:  J Pain Symptom Manage       Date:  2020-09-01       Impact factor: 3.612

4.  Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen.

Authors:  Brandon J Sonn; Kennon J Heard; Susan M Heard; Angelo D'Alessandro; Kate M Reynolds; Richard C Dart; Barry H Rumack; Andrew A Monte
Journal:  Clin Toxicol (Phila)       Date:  2021-05-28       Impact factor: 4.467

5.  Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine.

Authors:  Jenni Puurunen; Katriina Tiira; Katariina Vapalahti; Marko Lehtonen; Kati Hanhineva; Hannes Lohi
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.